Shares of FibroGen slid by a staggering 53.79% in 30 days from $-33.49 to $20.30 at 11:14 EST on Wednesday, following last session’s upward trend. NASDAQ Composite is rising 0.04% to $13,791.83, after two successive sessions in a row of losses. This seems, at the moment, a somewhat positive trend exchanging session today.
FibroGen’s last close was $20.35, 181.82% below its 52-week high of $57.21.
The company’s growth estimates for the current quarter and the next is 2.2% and 51.6%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $20.30 at 11:14 EST, way under its 52-week high of $57.21 and higher than its 52-week low of $19.70.
FibroGen’s Moving Average
FibroGen’s worth is way under its 50-day moving average of $39.14 and way below its 200-day moving average of $42.31.
More news about FibroGen.